» Articles » PMID: 32848627

What Have Advances in Transcriptomic Technologies Taught Us About Human White Matter Pathologies?

Overview
Specialty Cell Biology
Date 2020 Aug 28
PMID 32848627
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

For a long time, post-mortem analysis of human brain pathologies has been purely descriptive, limiting insight into the pathological mechanisms. However, starting in the early 2000s, next-generation sequencing (NGS) and the routine application of bulk RNA-sequencing and microarray technologies have revolutionized the usefulness of post-mortem human brain tissue. This has allowed many studies to provide novel mechanistic insights into certain brain pathologies, albeit at a still unsatisfying resolution, with masking of lowly expressed genes and regulatory elements in different cell types. The recent rapid evolution of single-cell technologies has now allowed researchers to shed light on human pathologies at a previously unreached resolution revealing further insights into pathological mechanisms that will open the way for the development of new strategies for therapies. In this review article, we will give an overview of the incremental information that single-cell technologies have given us for human white matter (WM) pathologies, summarize which single-cell technologies are available, and speculate where these novel approaches may lead us for pathological assessment in the future.

Citing Articles

Identification and validation of hub genes associated with biotic and abiotic stresses by modular gene co-expression analysis in Oryza sativa L.

Razalli I, Abdullah-Zawawi M, Zainal Abidin R, Harun S, Che Othman M, Ismail I Sci Rep. 2025; 15(1):8465.

PMID: 40069264 PMC: 11897307. DOI: 10.1038/s41598-025-92942-5.


Impact of fixation duration on messenger RNA detectability in human formalin-fixed paraffin-embedded brain tissue.

Hurler C, Liebscher S, Arzberger T, Jakel S Brain Commun. 2024; 6(6):fcae430.

PMID: 39659968 PMC: 11630792. DOI: 10.1093/braincomms/fcae430.


Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis.

van Wageningen T, Gerrits E, Brouwer N, Breve J, Geurts J, Eggen B Brain Commun. 2022; 4(2):fcac005.

PMID: 35282162 PMC: 8914505. DOI: 10.1093/braincomms/fcac005.


Oligodendroglia heterogeneity in the human central nervous system.

Seeker L, Williams A Acta Neuropathol. 2021; 143(2):143-157.

PMID: 34860266 PMC: 8742806. DOI: 10.1007/s00401-021-02390-4.


Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer.

Bakare O, Gokul A, Wu R, Niekerk L, Klein A, Keyster M Biomolecules. 2021; 11(8).

PMID: 34439786 PMC: 8394746. DOI: 10.3390/biom11081120.


References
1.
Hendrickx D, van Scheppingen J, van der Poel M, Bossers K, Schuurman K, van Eden C . Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions. Front Immunol. 2018; 8:1810. PMC: 5742619. DOI: 10.3389/fimmu.2017.01810. View

2.
Vistain L, Phan H, Keisham B, Jordi C, Chen M, Reddy S . Quantification of extracellular proteins, protein complexes and mRNAs in single cells by proximity sequencing. Nat Methods. 2022; 19(12):1578-1589. PMC: 11289786. DOI: 10.1038/s41592-022-01684-z. View

3.
Vieth B, Parekh S, Ziegenhain C, Enard W, Hellmann I . A systematic evaluation of single cell RNA-seq analysis pipelines. Nat Commun. 2019; 10(1):4667. PMC: 6789098. DOI: 10.1038/s41467-019-12266-7. View

4.
Broadwater L, Pandit A, Clements R, Azzam S, Vadnal J, Sulak M . Analysis of the mitochondrial proteome in multiple sclerosis cortex. Biochim Biophys Acta. 2011; 1812(5):630-41. PMC: 3074931. DOI: 10.1016/j.bbadis.2011.01.012. View

5.
Ding J, Adiconis X, Simmons S, Kowalczyk M, Hession C, Marjanovic N . Systematic comparison of single-cell and single-nucleus RNA-sequencing methods. Nat Biotechnol. 2020; 38(6):737-746. PMC: 7289686. DOI: 10.1038/s41587-020-0465-8. View